<DOC>
	<DOCNO>NCT01742975</DOCNO>
	<brief_summary>A randomized prospective simple-blind interventional study evaluate efficacy synthetic adhesive solution `` Ifabond '' , patient undergo breast cancer surgery . The main objective study determine application Ifabond , addition conventional method breast surgery , reduces postoperative seroma formation . The secondary objective ass quality life immediately surgery , need needle aspiration axilla , use Ifabond .</brief_summary>
	<brief_title>Efficacy Study Ifabond Breast Cancer Surgery</brief_title>
	<detailed_description>Breast cancer patient select preoperative visit surgeon , inform study answer question . Patients consent participate randomize one two arm : 1 . Arm A : Applying Ifabond 2 . Arm B : Without Ifabond Patients stratify accord two criterion : 1 . Axillary Lymph Node Dissection plan ( ALND ) 2 . Body Mass Index ( BMI ) The following parameter measure : - ECOG status Blood Pressure day 3 ( day 7 case ALND ) , day 15 day 30 post surgery - Volume drainage day 3 ( day 7 case ALND ) post surgery - Discomfort allege patient day 3 ( day 7 case ALND ) , day 15 day 30 post surgery - Lymphocele volume measure ultrasound day 15 day 30 post surgery - If volume ≥ 100cc , needle aspiration perform , volume aspirate document . - Adverse event concomitant medication collect throughout study 30 day last ultrasound .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Lymphocele</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>`` Eastern Cooperative Oncology Group '' ECOG status ≤ 2 Diagnosis invasive In situ breast cancer Patient undergo partial mastectomy without axillary lymph node dissection , ( without communication two surgical loge ) Pregnant breastfeed patient Participation another protocol Investigational drug ( within last 4 week enrollment ) Known hypersensitivity Cyanoacrylate Known hypersensitivity formaldehyde Patient experience systemic infection preoperatively , condition know interfere heal process Patient uncontrolled diabetes</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>